|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/17 | |
| A61K 31/27 | |||
| C07C 271/08 | |||
| C07C 275/18 | |||
| A61P 43/00 |
| (11) | Patento numeris | 2857015 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14182803.8 |
| Europos patento paraiškos padavimo data | 2009-03-17 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-04-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-05-05 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 69857 P | 2008-03-18 | US | |
| 123621 P | 2008-04-09 | US | |
| 207220 P | 2009-02-09 | US | |
| 209453 P | 2009-03-06 | US |
| (72) |
Tran, Thuy-Anh, US
Chen, Weichao, US
Kramer, Bryan A., US
Sadeque, Abu J. M., US
Shyfryna, Hanna L., US
Shin, Young-Jun, US
Vallar, Pureza, US
Zou, Ning, US
|
| (73) |
Arena Pharmaceuticals, Inc.,
6154 Nancy Ridge Drive, San Diego, CA 92121,
US
|
| (54) | Modulators of the prostacyclin (PG12) receptor useful for the treatment of disorders related thereto |
| Modulators of the prostacyclin (PG12) receptor useful for the treatment of disorders related thereto |